PRESS RELEASE published on 08/07/2025 at 07:17, 10 months 28 days ago Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information Valneva announces FDA's removal of recommended pause on Chikungunya Vaccine IXCHIQ® in elderly individuals and updates to the Prescribing Information, following EMA's recommendation. Updates reflect Serious Adverse Events and expanded Warnings and Precaution section FDA Valneva Chikungunya Vaccine Prescribing Information Vaccine Updates
BRIEF published on 07/28/2025 at 13:51, 11 months 6 days ago Valneva SE : Perspectives positives malgré les inquiétudes liées au chikungunya Biotechnologie Valneva SE Recherche Sur Les Actions Chikungunya Marché Des Vaccins
BRIEF published on 07/28/2025 at 13:51, 11 months 6 days ago Valneva SE: Positive Outlook Amid Chikungunya Concerns Biotech Valneva SE Equity Research Chikungunya Vaccine Market
PRESS RELEASE published on 07/28/2025 at 13:46, 11 months 6 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (FR0004056851) rating to Buy with a target price of €8.10 amidst global Chikungunya outbreak warning by WHO First Berlin Equity Research BUY Rating Valneva SE Chikungunya Outbreak EUR 8.10 Target Price
BRIEF published on 06/26/2025 at 07:05, 1 year ago Valneva Secures Exclusive Vaccine Distribution in Germany with CSL Seqirus Valneva Germany Market 2025 Sales Growth CSL Seqirus Vaccine Distribution
BRIEF published on 06/26/2025 at 07:05, 1 year ago Valneva obtient la distribution exclusive de son vaccin en Allemagne avec CSL Seqirus Marché Allemand Valneva CSL Seqirus Distribution Des Vaccins Croissance Des Ventes En 2025
PRESS RELEASE published on 06/26/2025 at 07:00, 1 year ago Valneva annonce un accord exclusif avec CSL Seqirus pour le marketing et la distribution de ses vaccins en Allemagne Valneva annonce un accord exclusif avec CSL Seqirus pour le marketing et la distribution de ses vaccins en Allemagne. Accord de 3 ans avec CSL Seqirus pour le marketing des vaccins IXCHIQ, IXIARO et DUKORAL de Valneva en Allemagne Allemagne Valneva Vaccins Accord Exclusif CSL Seqirus
PRESS RELEASE published on 06/26/2025 at 07:00, 1 year ago Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus Valneva SE announces exclusive vaccine marketing and distribution agreement for Germany with CSL Seqirus. CSL to commercialize Valneva's vaccines IXCHIQ®, IXIARO®, and DUKORAL® Distribution Agreement Germany Valneva SE CSL Seqirus Vaccine Marketing
BRIEF published on 06/25/2025 at 17:50, 1 year ago Valneva General Meeting Approves Key Resolutions Financial Guidance Annual Meeting Valneva Board Appointments Vaccine Company
BRIEF published on 06/25/2025 at 17:50, 1 year ago L'assemblée générale de Valneva approuve les principales résolutions Valneva Nominations Au Conseil D'administration Orientation Financière Assemblée Annuelle Entreprise De Vaccins
Published on 07/03/2026 at 23:00, 14 hours 12 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 15 hours 44 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 17 hours 42 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 23 hours 42 minutes ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 11:01, 2 hours 10 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 4 hours 6 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 18 hours 11 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 18 hours 16 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 18 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 21:49, 15 hours 22 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 15 hours 22 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 18 hours 29 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 18 hours 35 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026